If a patient has a family history of MS, would you treat the patient with a TNF Blocker or switch to something else?
Featuring Benjamin Lockshin, MD |
EVP of Strategic Initiatives | Published April 15, 2022
EVP of Strategic Initiatives
Director of the Clinical Trials Center
US Dermatology Partners